Amgen Inc.
ST2 antigen binding proteins
Last updated:
Abstract:
Described herein are compositions and methods related to antigen binding proteins that bind to human ST2, including antibodies. In particular embodiments, the disclosure provides fully human anti-ST2 antibodies and derivatives and variants thereof. Further provided are nucleic acids encoding such antibodies and antibody fragments, variants, and derivatives. Also, provided are methods of making and using such antibodies including methods of treating and preventing autoimmune and inflammatory disorders.
Status:
Grant
Type:
Utility
Filling date:
8 Jan 2019
Issue date:
13 Jul 2021